person

Andreas M.

Country
Germany
Department
Neuroscience Clinical Research Center

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
20
Sites with multiple studies

Has run more than one trial at 20 of 83 partner sites.

Specializations

Neuromuscular Disorders

The investigator demonstrates significant expertise in treating myasthenia gravis, with particular focus on both generalized and ocular manifestations of the condition. Their research encompasses innovative therapeutic approaches for managing autoimmune neuromuscular junction disorders.

  • Generalized Myasthenia Gravis (gMG)
  • Ocular Myasthenia Gravis (oMG)
  • AChR Antibody-Positive MG

Primary interest in evaluating novel biological therapies and targeted treatments for myasthenia gravis patients.

Neurological Emergency Medicine

The investigator specializes in the management of acute neurological conditions, with particular emphasis on status epilepticus in elderly populations. Their work focuses on emergency interventions for severe neurological presentations.

  • Established Status Epilepticus
  • Benzodiazepine-Resistant Seizures
  • Geriatric Neurology

Expertise in treating complex neurological emergencies in elderly patients requiring immediate intervention.

Therapeutic Development

The investigator is involved in evaluating innovative biological therapies for autoimmune neurological conditions. Their research includes assessment of various administration routes and dosing strategies for novel therapeutic agents.

  • Complement Inhibition Therapy
  • Subcutaneous Administration Studies
  • Combination Therapy Approaches

Focus on developing optimized treatment regimens and delivery methods for neurological therapeutics.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.